Abstract
In this study the relationship between the viscoelasticity/mechanical properties of metronidazole-containing aqueous polymer networks composed of HEC and PVP and drug release was statistically modelled. The networks were characterised using oscillatory analysis and drug release was performed using dissolution analysis (pH 7.4). Statistical modelling of the rheological properties and their relationship with drug release was performed using Analysis of Variance, Multivariate Analysis of Variance and stepwise regression. Modelling of drug release was performed using both the Korsmeyer-Peppas and Peppas-Sahlin models to understand the mechanism of drug release and the contributions of network swelling/erosion and diffusion on drug release. HEC and PVP were shown to significantly enhance the rheological properties of the networks. Furthermore, rheological synergy was observed whenever PVP was added to HEC and was due to non-covalent bond formation between these polymers. The magnitude of this synergy increased as functions of increasing concentrations of each polymer. Drug release was dependent on the concentration of HEC and independent of the presence of PVP. The release of metronidazole from networks composed of HEC 3% w/w and PVP (1–5% w/w) was controlled by network swelling/erosion whereas for the networks containing PVP and 5% and 10% w/w HEC, the dominant mechanism of drug release was diffusion. Limited correlation was observed between network rheological properties and drug release. It is suggested that this is due to dissociation of the HEC-PVP interactions and dissolution of PVP during drug release, resulting in a network structure whose properties are dominated by those of HEC. This is the first study that has statistically examined the role of binary polymer network viscoelasticity on drug release. Based on the findings of this study, caution should be shown when formulating aqueous networks with enhanced rheological properties as these effects may not necessarily contribute to other primary determinants of device performance, notably drug release.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.